Mitoquines in COPD

UnknownOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

June 1, 2021

Conditions
COPD Exacerbation
Interventions
OTHER

There is not intervention.

There is not intervention

Trial Locations (1)

39005

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Hospital Universitario Marqués de Valdecilla

OTHER

NCT04449419 - Mitoquines in COPD | Biotech Hunter | Biotech Hunter